Clinical trial
A Study of Ultrashort PRS Regimen V in the Treatment of MDR-TB
NCT05278988 is registered in ClinicalTrials.gov with Shanghai Pulmonary Hospital, Shanghai, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of Ultrashort PRS Regimen V in the Treatment of MDR-TB
- Lead sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 1, 2021
- Completion date
- October 30, 2024
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mdr-tb